Search
Search Results
##search.searchResults.foundPlural##
-
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1551PDF: 894HTML: 3148 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
10719PDF: 3377HTML: 1654 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1498PDF: 763HTML: 1193Untitled: 227Untitled: 195Untitled: 183Untitled: 197Untitled: 210 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1974PDF: 861HTML: 3699 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3072PDF: 1180HTML: 137 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2276PDF: 901HTML: 270 -
-
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3576PDF: 1698HTML: 722 -
ADVANCES IN THE TREATMENT OF MALARIA
2969PDF: 1376HTML: 6162 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1758PDF: 631HTML: 926 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1448PDF: 1227HTML: 169 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1842PDF: 671HTML: 305 -
IMMUNOLOGY OF TUBERCULOSIS
5920PDF: 2349HTML: 7374Untitled: 251 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2418PDF: 890HTML: 1707Figure 1: 259Table 1: 258 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
2231Suppl. Files: 970HTML: 606PDF: 844 -
-
TYROSINE KINASE INHIBITORS AND PREGNANCY
3845PDF: 1786HTML: 2766 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1383PDF: 1027HTML: 112 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
3096PDF: 1096HTML: 191 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
3008PDF: 1179HTML: 502Preferred Reviewers: 254 -
THE EMERGING RESISTANCE IN NOSOCOMIAL URINARY TRACT INFECTIONS: FROM THE PEDIATRICS PERSPECTIVE.
2218PDF: 1029HTML: 267The emerging resistance in nosocomial urinary tract infections: from the pediatrics perspective: 284 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1593PDF: 1028HTML: 454







